ArticleCurrent health sciences journal

Long Term Survivor with Erlotinib in Metastatic Lung Cancer-Squamous Cell Carcinoma Subtype.

Bogdan Ionel Vatu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.